Impact investor

4BIO Capital

Investor type

PE / VC

Last fund created

2014

AUM

$200 M

Location

Russia

$5-10 m

Investment Ticket

3-5 years

Investment Horizon

Seed, Series A

Investment Stage

IPO, Sale to strategic investor

Exit Strategy

Profile

4BIO Capital is an international venture capital firm focused solely on the advanced therapies sector. 4BIO’s objective is to invest in, support, and grow early stage companies developing treatments in areas of high unmet medical need, with the ultimate goal of ensuring access to these potentially curative therapies for all patients. Specifically, it looks for viable, high-quality opportunities in cell and gene therapy, RNA-based therapy, targeted therapies, and the microbiome. The 4BIO team comprises leading advanced therapy scientists and experienced life science investors who have collectively published over 250 scientific articles in prestigious academic journals including Nature, The Lancet, Cell, and the New England Journal of Medicine. 4BIO has both an unrivalled network within the advanced therapy sector and a unique understanding of the criteria that define a successful investment opportunity in this space.

Industry

Life Sciences MedTech Biotechnology

Region of investment

Europe North America Asia

Contacts

Upgrade to see contacts
Name
Title
Email
avatar
1gmY9h8DbLSJsvOU Managing Partner
Managing Partner
avatar
1gmY9h8DbLSJsvOU Investment Director
Investment Director
avatar
1gmY9h8DbLSJsvOU Partner
Partner
If there are no contacts of this investor, please write to us, we will try to find them as soon as possible and get back to you!